Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
European Association for Haemophilia and Allied Disorders, 2025 (EAHAD)
Annualised bleeding rates in patients with haemophilia A or B and inhibitors with and without target joints at baseline: Results from the concizumab phase 3 explorer7 study
European Association for Haemophilia and Allied Disorders, 2025 (EAHAD)